Amgen Inc.
US ˙ NasdaqGS ˙ US0311621009

SecurityAMGN / Amgen Inc.
InstitutionFirst Command Advisory Services, Inc.
Latest Disclosed Ownership2,212 shares
Latest Disclosed Value $ 778,293
First Command Advisory Services, Inc. reports 2.84% increase in ownership of AMGN / Amgen Inc.

On May 7, 2026 - First Command Advisory Services, Inc. filed a 13F-HR form disclosing ownership of 2,212 shares of Amgen Inc. (US:AMGN) valued at $778,292 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 2,151 shares of Amgen Inc.. This represents a change in shares of 2.84% during the quarter. The current value of the position is $748,143 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F Amgen Common Stock 031162100 2,212 61 2.84 778 10.51 0.0035
2026-02-11 2025-12-31 13F Amgen Common Stock 031162100 2,151 118 5.80 704 22.86 0.0049
2025-10-31 2025-09-30 13F Amgen Common Stock 031162100 2,033 -118 -5.49 574 -4.50 0.0042
2025-08-01 2025-06-30 13F Amgen Common Stock 031162100 2,151 0 0.00 601 -10.45 0.0052
2025-05-02 2025-03-31 13F Amgen Common Stock 031162100 2,151 -349 -13.96 670 2.92 0.0064
2025-02-05 2024-12-31 13F Amgen COM 031162100 2,500 0 0.00 652 -19.13 0.0062
2024-10-25 2024-09-30 13F Amgen Common Stock 031162100 2,500 -35 -1.38 806 1.64 0.0078
2024-07-26 2024-06-30 13F Amgen COM 031162100 2,535 2,535 792 0.0082
2024-05-02 2024-03-31 13F Amgen COM 031162100 0 -2,621 -100.00 0 -100.00
2024-02-01 2023-12-31 13F Amgen COM 031162100 2,621 -43 -1.61 755 5.45 0.0088
2023-11-08 2023-09-30 13F Amgen Common Stock 031162100 2,664 2,664 716 0.0094
2023-04-14 2023-03-31 13F AMGEN INC COM COM 031162100 0 -19 -100.00 0 0.0000
2023-01-20 2022-12-31 13F AMGEN INC COM COM 031162100 19 19 0 0.0000
2022-01-25 2021-12-31 13F AMGEN INC COM COM 031162100 0 -14 -100.00 0 0.0000
2021-11-12 2021-09-30 13F AMGEN INC COM COM 031162100 14 14 0 0.0000
2021-01-19 2020-12-31 13F AMGEN INC COM COM 031162100 0 -45 -100.00 0 -100.00
2020-10-19 2020-09-30 13F AMGEN INC COM COM 031162100 45 45 11 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.